PHARMACEUTICAL COMPOSITION CONTAINING CYCLOALKYL UREA DERIVATIVE

To provide an agent for treating or preventing diseases associated with an orexin receptor, particularly an orexin 2 receptor.SOLUTION: This invention relates to an agent for treating or preventing diseases such as narcolepsy, idiopathic hypersomnia, hypersomnia, sleep apnea syndrome, the agent cont...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	UESUGI JUNICHIRO, IDEGAMI EIJI, RI KANEMITSU, KOMIYA MASABUMI, FUNAKOSHI YUTA
Format:	Patent
Sprache:	eng ; jpn
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	To provide an agent for treating or preventing diseases associated with an orexin receptor, particularly an orexin 2 receptor.SOLUTION: This invention relates to an agent for treating or preventing diseases such as narcolepsy, idiopathic hypersomnia, hypersomnia, sleep apnea syndrome, the agent containing a novel compound having a urea skeleton represented by formula (1) or a pharmaceutically acceptable salt thereof as an active ingredient.SELECTED DRAWING: None 【課題】オレキシン受容体、特にオレキシン２型受容体が関与する疾患に対する治療薬または予防薬を提供する。【解決手段】式（１）で表されるウレア骨格を有する新規な化合物またはそれらの製薬学的に許容される塩を有効成分として含有する、ナルコレプシー、特発性過眠症、過眠症、睡眠時無呼吸症候群等の疾患の治療薬または予防薬に関する。TIFF2022183120000336.tif4159【選択図】なし